Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Virginie Galibert"'
Autor:
Margaux Bieuville, Dominique Faugère, Virginie Galibert, Morgane Henard, Antoine M. Dujon, Beata Ujvari, Pascal Pujol, Benjamin Roche, Frédéric Thomas
Publikováno v:
Frontiers in Ecology and Evolution, Vol 11 (2023)
It is increasingly thought that part of human susceptibility to cancer is the result of evolutionary mismatches: our ancestors evolved cancer suppression mechanisms in a world largely different from our modern environments. In that context, it has be
Externí odkaz:
https://doaj.org/article/894a1e07df3948fcae3dee97700bdd17
Autor:
Pascal Pujol, Kevin Yauy, Amandine Coffy, Nicolas Duforet-Frebourg, Sana Gabteni, Jean-Pierre Daurès, Frédérique Penault Llorca, Frédéric Thomas, Kevin Hughes, Clare Turnbull, Virginie Galibert, Chloé Rideau, Carole Corsini, Laetitia Collet, Benoit You, David Geneviève, Nicolas Philippe
Publikováno v:
Cancers, Vol 14, Iss 13, p 3266 (2022)
Background: Poly(ADP-ribose) polymerase 1 inhibitor (PARPi) agents can improve progression-free survival of patients with breast cancer who carry a germline BRCA1 or BRCA2 pathogenic or likely pathogenic variant (gBRCA) in both the metastatic and adj
Externí odkaz:
https://doaj.org/article/ee4cdd610eed4da9bf33a007b3b92391
Autor:
Marion Imbert-Bouteille, Carole Corsini, Marie-Christine Picot, Lucas Mizrahy, Sandrine Akouete, Helena Huguet, Frédéric Thomas, David Geneviève, Patrice Taourel, Marc Ychou, Virginie Galibert, Chloé Rideau, Karen Baudry, Tatiana Kogut Kubiak, Isabelle Coupier, Rémy Hobeika, Yvette Macary, Alain Toledano, Jérôme Solassol, Antoine Maalouf, Jean-Pierre Daures, Pascal Pujol
Publikováno v:
Genes, Vol 12, Iss 7, p 1100 (2021)
According to clinical guidelines, the occurrence of very early-onset breast cancer (VEO-BC) (diagnosed ≤ age 30 years) or VEO ovarian cancer (VEO-OC) (diagnosed ≤ age 40 years) in families with BRCA1 or BRCA2 mutation (BRCAm) prompts advancing th
Externí odkaz:
https://doaj.org/article/d6823048128045799adbe5d88e11e39f
Autor:
Pascal, Pujol, Kevin, Yauy, Amandine, Coffy, Nicolas, Duforet-Frebourg, Sana, Gabteni, Jean-Pierre, Daurès, Frédérique, Penault Llorca, Frédéric, Thomas, Kevin, Hughes, Clare, Turnbull, Virginie, Galibert, Chloé, Rideau, Carole, Corsini, Laetitia, Collet, Benoit, You, David, Geneviève, Nicolas, Philippe
Publikováno v:
Cancers. 14(13)
Poly(ADP-ribose) polymerase 1 inhibitor (PARPi) agents can improve progression-free survival of patients with breast cancer who carry a germline BRCA1 or BRCA2 pathogenic or likely pathogenic variant (gBRCA) in both the metastatic and adjuvant settin
Autor:
Pascal Pujol, Kévin Yauy, Amandine Coffy, Nicolas Duforet-Frebourg, Sana Gabteni, Jean-Pierre Daurès, Frédérique Penault-Llorca, Frédéric Thomas, Kevin Hughes, Clare Turnbull, Virginie Galibert, Chloé Rideau, Laetitia Collet, Benoit You, David Geneviève, Nicolas Philippe
Publikováno v:
Journal of Clinical Oncology. 40:551-551
Background: PARP inhibitor (PARPi) agents can improve progression-free survival of patients with breast cancer (BC) who carry a germline BRCA1 or BRCA2 pathogenic or likely pathogenic variant (gBRCA1/2) in both the metastatic and adjuvant setting. Th
Autor:
Marion Vandromme, Jean Philippe Spano, Olivier Cussenot, Chloé Rideau, Carole Corsini, Isabelle Treilleux, Michèle Vintraud, Ignace Vergote, Yves-Jean Bignon, Kevin S. Hughes, Bernard Baertschi, Eitan Friedman, Daniel Zarca, Marie Duboys de Labarre, Pascal Pujol, Jean Marc Rey, Joseph Gligorov, Ettore D. Capoluongo, Clarisse Duriez, Marion Imbert-Bouteille, Yann Neuzillet, Jean-Louis Mandel, Isabelle Ray-Coquard, Laurence Gladieff, Jose E. Alés Martínez, Frédérique Penault-Llorca, Karim Fizazi, Pierre Jean Lamy, Julie A. Vendrell, Pascal Hammel, Thibault De La Motte Rouge, Jesus Garcia Foncillas, Diether Lambrechts, Tatiana Kogut-Kubiak, Karen Baudry, William Jacot, William D. Foulkes, Frédéric Thomas, Sophie Nambot, Massimo Barberis, Michèle Anahory, Matti Aapro, Xavier Rebillard, Josep M. Piulats, Florence Duchamp, Steven A. Narod, Sylviane Olschwang, Banu Arun, Marc Bollet, Philp Beer, Clare Turnbull, Helen Hanson, Nicola Normanno, Virginie Galibert
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
European Journal of Cancer
European Journal of Cancer, 2021, 146, pp.30-47. ⟨10.1016/j.ejca.2020.12.023⟩
European Journal of Cancer, Elsevier, 2021, 146, pp.30-47. ⟨10.1016/j.ejca.2020.12.023⟩
Universidad de Barcelona
European Journal of Cancer
European Journal of Cancer, 2021, 146, pp.30-47. ⟨10.1016/j.ejca.2020.12.023⟩
European Journal of Cancer, Elsevier, 2021, 146, pp.30-47. ⟨10.1016/j.ejca.2020.12.023⟩
BRCA1 and BRCA2 gene pathogenic variants account for most hereditary breast cancer and are increasingly used to determine eligibility for PARP inhibitor (PARPi) therapy of BRCA-related cancer. Because issues of BRCA testing in clinical practice now o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d68784e83fff96e28dfb34c7477a991a
http://hdl.handle.net/2445/176353
http://hdl.handle.net/2445/176353
Autor:
Tatiana Kogut Kubiak, Marc Ychou, Lucas Mizrahy, Jérôme Solassol, Carole Corsini, Virginie Galibert, Sandrine Akouete, Marion Imbert-Bouteille, Karen Baudry, David Geneviève, Antoine Maalouf, Pascal Pujol, Patrice Taourel, Remy Hobeika, Chloé Rideau, Frédéric Thomas, Helena Huguet, Yvette Macary, Alain Toledano, Jean-Pierre Daurès, Isabelle Coupier, Marie-Christine Picot
Publikováno v:
Genes
Genes, 2021, 12 (7), pp.1100. ⟨10.3390/genes12071100⟩
Genes, Vol 12, Iss 1100, p 1100 (2021)
Volume 12
Issue 7
Genes, 2021, 12 (7), pp.1100. ⟨10.3390/genes12071100⟩
Genes, Vol 12, Iss 1100, p 1100 (2021)
Volume 12
Issue 7
According to clinical guidelines, the occurrence of very early-onset breast cancer (VEO-BC) (diagnosed ≤ age 30 years) or VEO ovarian cancer (VEO-OC) (diagnosed ≤ age 40 years) in families with BRCA1 or BRCA2 mutation (BRCAm) prompts advancing th
Autor:
Paul Vilquin, Virginie Galibert, Hesham El Ghazaly, Marie-Christine Picot, Paul Ihout, Helena Bertet, Asma Mouhout, Ahmed Gaballah, Karen Baudry, David Khayat, Alain Toledano, Yazid Belkacemi, Hamouda Boussen, Jean-Marc Rey, Céline Bourgier, Isabelle Coupier, Carole Corsini, Dalel Ben Nejima, Pascal Pujol, Sarra Henouda, Louise Biquard, Assia Bensalem, Faouzi Habib
Publikováno v:
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 2017, 166 (2), pp.631--639. ⟨10.1007/s10549-017-4434-y⟩
Breast Cancer Research and Treatment, 2017, 166 (2), pp.631--639. ⟨10.1007/s10549-017-4434-y⟩
International audience; PURPOSE: This report compares the risk factors, the tumor phenotypes, and the BRCA1/BRCA2 genotype of early onset breast cancer (EOBC) patients between Southern Europe and North Africa. METHODS: Four hundred and fifty six wome
Autor:
Isabelle Coupier, Jérôme Solassol, Virginie Galibert, Jean Chiesa, Lydie Bernhard, Solange Carton, Pierre Vande Perre, Ornellia Mophawe, Jean Marc Rey, Laura Robert, Valérie Macioce, Aude Michel, Marie-Christine Picot, Noëlle Bastide, Helena Bertet, Frédéric Thomas, Pascal Pujol, Carole Corsini, Yves-Jean Bignon, Nathalie Alegre
Publikováno v:
Psycho-Oncology
Psycho-Oncology, Wiley, 2019, 28 (8), pp.1679-1686. ⟨10.1002/pon.5142⟩
Psycho-Oncology, Wiley, 2019, 28 (8), pp.1679-1686. ⟨10.1002/pon.5142⟩
International audience; ObjectiveIntrafamilial disclosure of hereditary cancer predisposition in BRCA1/2 and mismatch repair gene (MMR) syndromes allows appropriate prevention strategies in at‐risk relatives. We previously showed in a nationwide st
Autor:
Daniel Zarca, Anne-Paule Gimenez-Roqueplo, Carole Corsini, Dominique Vaur, Nelly Burnichon, Sylviane Olschwang, Christian Hervé, Stéphane Richard, Virginie Galibert, Pascal Pujol, Nadem Soufir, Thierry Frebourg, I. Raingeard, Pierre Vande Perre, Sophie Giraud, Laurence Faivre, Xavier Rebillard, Michèle Anahory, Damien Sanlaville, Olivier Ingster, Muriel Le Bidan, Marc Spielmann, Alain Toledano, Anne Cambon-Thomsen, Brigitte Bressac-de Paillerets, Elisabeth Luporsi, Bernard Baertschi, David Azria, Olivier Cussenot, Pascal Hammel, Noëlle Bastide, Karen Baudry, Isabelle Coupier, Olivier Putois, Arash Rafii, Jean-Philippe Spano, Joseph Gligorov, Sarah Amar, Caroline Zorn, Patricia Niccoli, Michèle Vintraud, Anne-Sophie Lapointe, Olivier Caron, Jean-Marc Rey, David Geneviève, Pierre Le Coz
Publikováno v:
European Journal of Human Genetics
European Journal of Human Genetics, 2018, 26 (12), pp.1732-1742. ⟨10.1038/s41431-018-0224-1⟩
European Journal of Human Genetics, Nature Publishing Group, 2018, 26 (12), pp.1732-1742. ⟨10.1038/s41431-018-0224-1⟩
European Journal of Human Genetics, 2018, 26 (12), pp.1732-1742. ⟨10.1038/s41431-018-0224-1⟩
European Journal of Human Genetics, Nature Publishing Group, 2018, 26 (12), pp.1732-1742. ⟨10.1038/s41431-018-0224-1⟩
IF 3.636 (2017); International audience; In oncology, the expanding use of multi-gene panels to explore familial cancer predisposition and tumor genome analysis has led to increased secondary findings discoveries (SFs) and has given rise to important
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe39cbca491f5aa5df412a9e2133e01
https://hal.umontpellier.fr/hal-01870352
https://hal.umontpellier.fr/hal-01870352